Argent Trust Co’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,888
Closed -$248K 710
2025
Q1
$248K Buy
+3,888
New +$226K 0.01% 613
2024
Q3
Sell
-7,592
Closed -$398K 723
2024
Q2
$398K Buy
7,592
+103
+1% +$4.52K 0.02% 465
2024
Q1
$305K Buy
7,489
+432
+6% +$16.2K 0.01% 521
2023
Q4
$261K Sell
7,057
-195
-3% -$7.34K 0.01% 533
2023
Q3
$277K Hold
7,252
0.02% 504
2023
Q2
$262K Buy
+7,252
New +$247K 0.01% 531
2023
Q1
Sell
-3,987
Closed -$227K 533
2022
Q4
$227K Buy
+3,987
New +$204K 0.02% 475

Other funds holding HALO

Argent Trust Co's HALO Position: Q2 2025 in Review

Argent Trust Co sold out of Halozyme (HALO) in Q2 2025, closing a stake of 3,888 shares — an estimated $248K sold.

Argent Trust Co first reported a position in HALO in Q4 2022 and held it in 7 quarters. The position peaked at $398K in Q2 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Argent Trust Co reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Argent Trust Co sold 3,888 Halozyme shares in Q2 2025, an estimated $248K.
  • Argent Trust Co first reported a position in Halozyme in Q4 2022 and held it in 7 quarters.
  • Argent Trust Co's Halozyme position peaked at $398K in Q2 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Argent Trust Co's 13F filing for Q2 2025, filed 12 Aug 2025.